机器人辅助步态训练与常规治疗对严重残疾进展型多发性硬化患者移动能力的效果(RAGTIME):随机对照试验研究方案
RAGTIME为平行组随机对照试验,计划纳入98例EDSS 6-7分的进展型多发性硬化患者,随机接受4周内12次每次2小时的机器人辅助步态训练(Lokomat)或常规物理治疗。主要结局为计时25英尺步行测试评估的步态速度,并探索神经可塑性相关临床与循环生物标志物变化。
要点
- RAGTIME试验比较机器人辅助步态训练与常规治疗对进展型多发性硬化移动能力的效果。
- 计划纳入98例EDSS 6-7分患者,随机分配至RAGT或常规物理治疗,每组49例。
- 主要结局为计时25英尺步行测试评估的步态速度,并探索神经可塑性生物标志物。
核心结论
- RAGT训练预期较主动对照干预改善进展型多发性硬化患者的移动能力。
- 本研究的独特之处在于分析多种潜在可塑性标志物与临床结局的关系。
研究设计与样本
- 平行组随机对照试验,评估者设盲。
- 计划纳入98例进展型多发性硬化患者(每组49例),EDSS量表6-7分。
- 干预为4周内12次每次2小时的训练(每周3次),随机分配至机器人辅助步态训练(Lokomat,Hocoma,瑞士)或个体化常规物理治疗(聚焦于使用习惯性步行辅助器具进行平地步行训练)。
- 结局测量在四个时间点进行:基线(首次干预前)、中期(6次训练后)、治疗结束(完成12次训练后)和随访(训练结束后3个月)。
主要发现
- 原文未报告结果。
关键数值与推荐
- 主要结局为步态速度,采用计时25英尺步行测试评估。
- 次要评估包括步行耐力、平衡、抑郁、疲劳和生活质量,以及仪器化实验室标志物(肌肉代谢、脑静脉血流动力学、皮层激活)和循环实验室标志物(稀有循环细胞群、促炎和抗炎细胞因子/趋化因子、生长因子、神经营养因子、凝血因子、转录组分析提示的其他血浆蛋白及代谢参数)。
- 训练参数(膝关节和髋关节驱动扭矩、跑台速度、体重支撑)在首次训练时设定,并在训练进展中逐步调整。
临床怎么用
- 原文未据此给出推荐。
局限性
- 试验注册为回顾性注册(2015年1月19日注册)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Gait and mobility impairments affect the quality of life (QoL) of patients with progressive multiple sclerosis (MS). Robot-assisted gait training (RAGT) is an effective rehabilitative treatment but evidence of its superiority compared to other options is lacking. Furthermore, the response to rehabilitation is multidimensional, person-specific and possibly involves functional reorganization processes. The aims of this study are: (1) to test the effectiveness on gait speed, mobility, balance, fatigue and QoL of RAGT compared to conventional therapy (CT) in progressive MS and (2) to explore changes of clinical and circulating biomarkers of neural plasticity. METHODS: This will be a parallel-group, randomized controlled trial design with the assessor blinded to the group allocation of participants. Ninety-eight (49 per arm) progressive MS patients (EDSS scale 6-7) will be randomly assigned to receive twelve 2-h training sessions over a 4-week period (three sessions/week) of either: (1) RAGT intervention on a robotic-driven gait orthosis (Lokomat, Hocoma, Switzerland). The training parameters (torque of the knee and hip drives, treadmill speed, body weight support) are set during the first session and progressively adjusted during training progression or (2) individual conventional physiotherapy focusing on over-ground walking training performed with the habitual walking device. The same assessors will perform outcome measurements at four time points: baseline (before the first intervention session); intermediate (after six training sessions); end of treatment (after the completion of 12 sessions); and follow-up (after 3 months from the end of the training program). The primary outcome is gait speed, assessed by the Timed 25-Foot Walk Test. We will also assess walking endurance, balance, depression, fatigue and QoL as well as instrumental laboratory markers (muscle metabolism, cerebral venous hemodynamics, cortical activation) and circulating laboratory markers (rare circulating cell populations pro and anti-inflammatory cytokines/chemokines, growth factors, neurotrophic factors, coagulation factors, other plasma proteins suggested by transcriptomic analysis and metabolic parameters). DISCUSSION: The RAGT training is expected to improve mobility compared to the active control intervention in progressive MS. Unique to this study is the analysis of various potential markers of plasticity in relation with clinical outcomes. TRIAL REGISTRATION: ClinicalTrials.gov, identifier: NCT02421731 . Registered on 19 January 2015 (retrospectively registered).
引用
- Straudi S, Manfredini F, Lamberti N, et al. The effectiveness of Robot-Assisted Gait Training versus conventional therapy on mobility in severely disabled progressIve MultiplE sclerosis patients (RAGTIME): study protocol for a randomized controlled trial. Trials. 2017. PMID: 28241776. doi:10.1186/s13063-017-1838-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。